Guo-Sheng Hu1, Zao-Zao Zheng2, Yao-Hui He3

  • 1Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China; State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China; Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China; Xiang An Biomedicine Laboratory, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China.

概括

这项研究整合了13种癌症类型的蛋白质基因和转录基因数据,以确定关键的失调基因和途径. 研究结果揭示了新的泛癌诊断生物标志物,预后模型,以及精确瘤学的潜在药物标.